Newspaper Publication of extract of Consolidated Unaudited Financial Results for the quarter and nine months ended December 31, 2025.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech has published extracts of its consolidated unaudited financial results for the quarter ended December 31, 2025 (Q3 FY26) and the nine months ended on the same date in newspapers. This is a routine regulatory requirement under SEBI's Listing Obligations and Disclosure Requirements (LODR) norms, where listed companies must publish a summary of their quarterly results in at least one English and one regional language newspaper. The detailed financial numbers and performance commentary would have already been disclosed earlier in the stock exchange filing. Investors should refer to the original results announcement for full details on revenue, profitability, and segment performance.
This is a standard compliance filing and does not contain new information beyond what was already disclosed in the official results announcement to the exchanges. No material impact on shareholders or stock price is expected from this particular publication.